Document Detail


Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis.
MedLine Citation:
PMID:  23283538     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The objective of this study was to examine the safety and efficacy of mizoribine (MZR), an inhibitor of inosine monophosphate dehydrogenase, in patients with connective tissue diseases (CTDs) other than rheumatoid arthritis. We identified all patients who had ever been treated with MZR for CTDs at our institution during the period from January 2001 to May 2011. A retrospective review of medical records was performed to evaluate safety and efficacy of MZR. A total of 63 patients (13 induction and 50 maintenance therapy with MZR) were included. During 70.2 patient-years of follow-up, only one patient required discontinuation of MZR due to an adverse event. Doses of PSL were significantly decreased at last follow-up in both the induction (45.2 ± 15.6 vs. 8.4 ± 5.7 mg/day, p < 0.01) and the maintenance group (12.4 ± 7.6 vs. 9.3 ± 6.4 mg/day, p < 0.01). MZR appears to be a safe and well-tolerated steroid-sparing agent in patients with CTDs.
Authors:
Ryo Rokutanda; Mitsumasa Kishimoto; Sachiko Ohde; Hisanori Shimizu; Atsushi Nomura; Yasuhiro Suyama; Yuri Ohara; Kenichi Yamaguchi; Masato Okada
Related Documents :
24261758 - Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a re...
24509338 - Selected parameters of hemostasis in patients with myeloproliferative neoplasms.
23314858 - Portal vein thrombosis in patients with end stage liver disease awaiting liver transpla...
23008938 - The asymmetric gait toenail unit sign.
24261758 - Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a re...
20464168 - Autonomic control of heart rate in patients with chronic cardiorespiratory disease and ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Rheumatology international     Volume:  -     ISSN:  1437-160X     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Allergy and Rheumatology, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan, rrokutandah1@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Speciation and Size Distribution of Copper and Zinc in Urban Road Runoff.
Next Document:  Is phonophoresis effective in the treatment of chronic low back pain? A single-blind randomized cont...